Outcomes for the 192 patients with proven p16-positive disease according to RPLN status are shown in Figure 2 , with a nonsignificant trend for inferior outcomes for p16-positive patients with involved RPLN compared to those without.
← all excerpts
Retropharyngeal Lymph Node Involvement in Oropharyngeal Carcinoma: Impact upon Risk of Distant Metastases and Survival Outcomes.
1
—
—